Compare CME & MMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CME | MMM |
|---|---|---|
| Founded | 1898 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.5B | 81.8B |
| IPO Year | 2002 | N/A |
| Metric | CME | MMM |
|---|---|---|
| Price | $273.13 | $168.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 10 |
| Target Price | ★ $285.33 | $165.30 |
| AVG Volume (30 Days) | 2.0M | ★ 2.8M |
| Earning Date | 10-22-2025 | 01-20-2026 |
| Dividend Yield | ★ 3.95% | 1.73% |
| EPS Growth | ★ 8.52 | N/A |
| EPS | ★ 10.32 | 6.26 |
| Revenue | $6,385,200,000.00 | ★ $24,825,000,000.00 |
| Revenue This Year | $6.91 | N/A |
| Revenue Next Year | $4.98 | $3.25 |
| P/E Ratio | ★ $26.51 | $26.98 |
| Revenue Growth | ★ 5.81 | 1.05 |
| 52 Week Low | $224.62 | $121.98 |
| 52 Week High | $290.79 | $174.69 |
| Indicator | CME | MMM |
|---|---|---|
| Relative Strength Index (RSI) | 50.20 | 53.99 |
| Support Level | $265.25 | $162.29 |
| Resistance Level | $273.34 | $170.00 |
| Average True Range (ATR) | 4.56 | 2.86 |
| MACD | -0.91 | -0.54 |
| Stochastic Oscillator | 46.52 | 54.48 |
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.